New blood filter aims to prevent organ failure in severe burn victims
NCT ID NCT07568132
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a blood-filtering device called Efferon LPS in 50 people with severe burns. The goal is to see if it can reduce dangerous inflammation and prevent organ failure. Participants will either receive standard care or standard care plus the blood filter. The study focuses on safety and how well the device works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURNS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
N.V. Sklifosovsky Research Institute for Emergency Medicine
Moscow, 129090, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI learns to see burns on hands, head, and feet
- Border-Region study investigates whether nationality affects burn survival
- Can a 4-session talk therapy prevent PTSD after a burn injury?
- 3D-Printed orthosis could ease burn scarring
- Vibration therapy shows promise for burn recovery in children
- New mineral spray shows promise for faster wound healing